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SLYCOPROTEIN OEPOSITIOH IN VASCULAR WALLS OF 
DIABETIC RETINOPATHY STUDIEC BY lMMUNOHlSTOCHEMlSTRY 
T. Bek’ and’ T. Lade? 
Puroose: Proliferative diabetic retinopathy is assumed to develop 
because vasogenic factors are released from retinal areas that are 
ischaemic and hypoxic secondary to occlusion of the retinal 
vascular bed. It has been propclsed that vascular occlusion in 
diabetic retinopethy may be due to the deposition of periodic acid 
Schiff positive glycoprotein compounds in the retinal vascular walls. 
but the role of these glycoproteins for retinal vascular occlusion has 
not been established. 
Methods; Periodic acid Schiff staining and immunohistochemistry 
to laminin, fibronectin, vitronectin .and type VI collagen was studied 
in eleven areas of capillary closure and eleven adjacent control 
areas from seven eyes of five diabetic patients, and in five 
midperipheral areas from five eyes of five age-matched controls. In 
each eye from diabetic patients the localized vascular lesions were 
identified from casts of the retinal vascular system. 
Beg&& In the retina from diabetic patients there was a 
significantly higher number of vessels showing periodic acid Schiff 
staining and immunoreactivity to the studied glycoproteins. 
However, there was no difference between the number of 
glycoprotein containing vessels in areas of vascular occlusion and 
in adjacent control areas in diabetic patients, and the material 
occluding the lumen centrally in areas of vascular occlusion did not 
show any glycoprotein staining or immunoreactivity. 
Conclusion% The findings confirm that glycoproteins are deposited 
in the vascular walls of diabetic retinopathy, but the findings also 
suggest that other factors are involved in causing vascular 
occlusion in this disease. 
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RETINOPATHY IN IDDM IN EUROPE, THE RURODIAB IDDM COMPLI- 
CATIONS STUDY. 
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CATIONS STUDY GROUP. 
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Prqose To asses the frequency of retinopad~y in IDDM, and iawa@te 
potentially modifisble risk factors. 
A4erkd.r In a multimntre, cmss-smtio;nal study of 3250 IDDM pstiaata from 31 
European ditiea eentrea retinopatby was assassed and r&ted to Hb-&, 
ahmin excretion rate, blood Presswe., &olesteml, kigIycaide SKI tibrinogm. 
Retinopathy ww evaluated by ~eoUall:y graded rainal pbotogmpbs. L&oratory 
values were assessed centrally. Blood pressure was measured with random zero 
sphygmomawmeter. 
Resullc Non-proliferative retioopathy WBS preaaat in 35.6%, pmliie in 
10.6% of patient?. Significant risk faaors for moderate/severe non-pmlifamtiva 
retinopathy were blood pressure and triglyceride, and for pmlife-rative retiwpathy 
uiglyceride aod fibrinogen. 
~onclusionr Vision threatening retinopathy is a eommoa mmplication in IDDM. 
Apart from glycemic control, several otiher potantially modifiable risk factors may 
be important, such ss raised blood pre-#sore, plasma higlycuide and fibrinogen. 
EOQ CHANGES IN NON-PROLIFERATIVE AND PROLIFERATIVE 
DIABETIC RETINDPATHY. 
TZEKOV R., TANEV V. 
Char of Cphthalmo!ogy, Higher Medical School, Sofle (Bufgarla) 
E~~Qs& The akn of our study ~8:’ to clartfy the EDQ alanges h 
prolferative (PDR) and non-proltferathre (NPDR) dtabettcrethopaihy. 
Mehods. The EOG procedure used was close to that descrbed by 
Arden et al. (1962)f. 35 diabettc patlenis (141 eyes) were tested (97 eyes 
of patients wlih NPDR and 44 eyes ot patients with PDF+). On all patients 
ftuoresceh angtography was performed prlcr the EDQ testhg. 16 
healthy subjects (32 eyes) served as a control group. Arden tndex, 
lmpllcii time of the dark trough (DT) and bnplicli ime of the ltght peak 
(LP) were evaluated.. ModHkatlons of the t-test and lhear conelattcn test 
were used. 
Et.as~& When compared with the values of me control group, tie 
values oi the Arden index and LP h NPDR presented signiftcant 
dMerences @ -C 0.002). The sama was present between control group 
and PDR eyes fp < 0.001) The DTvatues did not show any dtlference h 
both NPDR end PDR eyes compared wlih those of healthy eyes When 
parameters were compared between NPDR end PDR eyes, only Arden 
hdex vabres showed slgnttlcant dtfferences $ c 0.001). When lhear 
correlation test was performed only NPDR eyes presented signtfttnt 
oxrelation behveen LP values end the extend of ischemla and oedema 
of the posterior pole. 
Conclusions. The Arden index is the most sensitive indicator of EOD 
parameters when testing pailents with dlabetlc rethopaihy. In NPDR 
eyes, the lmpl!cli ilme of LP reflects the extend of some pathologic 
changes h the retina. 
1. Arden G., A.Banada, J. Kelsey New clhkel test of rettnal function 
based upon the standing potenilal of the eye. Br.J.Ophih 1962,/46/:449- 
467. 
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AL)ENtJSlNE IS A NEURVPROTECTNE AGENT IN KETINAL 
ISCI+EMLA. 
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A large body of evidence exists to show that adenosine receptor agonists act as 
neuropmtective agents in tmin iscbaemia (1). However, only a single 
pdfmhmy stody bas been carried out to support such a role in rhe retina (2). 
In tbc present commuhxtion we provide detailed conviocing evidence that 
adenosine receptor agonists can be used to attenuate tbe manifestations of 
ischaemia 
Ischaemia was induced to the rat retina by raising the in!raocular presswe (120 
nmHg) above the systolic blood pressure for 45 min. Three days after 
nperfusion the b-wave of the elccuoretiogmm in these animals was reduced by 
47 f 5% (n= 13) compared with preiscbaemic valoes. In addition a change in 
tbe nature of the cakednio immtmostsioiig pattern in the retina was apparent. 
The cbamcteristic three tands of cake&n immtmoreactivity in the inner 
plexifom~ layer were reduced to a single baod. In addition mxphometric 
analysis of plastic embedded retinal sections showed a siflcant “thiig” of 
the ioner plexiform layer. 
To exsmim the effect of adenosine agonists on retinal ischaemia, 2~1 adewsine 
demimse (ADA; 5u io viaeous humour) or the ADA inhibitor E%INA 
(250uM in viuwus humour) was injected into the vitreous humour just before 
delivering an ischaemic insult In other aoimals the adenosioe agonist R-PIA 
was lojected i.p. (0.2nigkg) just before irchaemia and once daily for the 
following hvo days. The results showed that EHNA and R-PL4 were 
neuqmxective in that tbe bwaw. of the elecumednogram was not reduced, 
the calretinio immunoreacrivity was unchanged and no evidence for “ddmdng” 
in the inner plexiform layer was apparent. Io contrast there was suggestive 
evidence for ADA exacerbates ischaemia. 
[l] Rudolphi K.A. et al., TIPS 13, (1992) 439-445. [2] Rosenbaum P.S et al., 
Invest. Ophthal. Vis. Sci. 33, (1992) 1125. 
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